Disproportionality analysis of pyoderma gangrenosum reporting to the FDA Adverse Event Reporting System in association with antirheumatic biologics.
Saved in:
| Title: | Disproportionality analysis of pyoderma gangrenosum reporting to the FDA Adverse Event Reporting System in association with antirheumatic biologics. |
|---|---|
| Authors: | Woods RH; Levin, Papantonio, Proctor, Buchanan, O'Brien, Barr & Mougey, P.A., 316 South Baylen Street, Pensacola, FL, 32502, USA. rwoods@levinlaw.com. |
| Source: | Clinical rheumatology [Clin Rheumatol] 2026 Jul; Vol. 45 (7), pp. 4609-4614. Date of Electronic Publication: 2026 Jun 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1434-9949 |
|---|---|
| DOI: | 10.1007/s10067-026-08237-1 |
